NASDAQ:AMEH - Apollo Medical Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $19.08 -0.21 (-1.09 %) (As of 05/19/2019 04:00 PM ET)Previous Close$19.08Today's Range$19.05 - $19.3652-Week Range$13.01 - $30.00Volume46,272 shsAverage Volume32,415 shsMarket Capitalization$682.49 millionP/E Ratio65.79Dividend YieldN/ABeta-1.08 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Apollo Medical Holdings, Inc., an integrated health care delivery and management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company serves the patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organizations; and non-insured patients in California. Apollo Medical Holdings, Inc. is based in Alhambra, California. Receive AMEH News and Ratings via Email Sign-up to receive the latest news and ratings for AMEH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Management consulting services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AMEH Previous Symbol CUSIPN/A CIK1083446 Webapollomed.net Phone626-282-0288Debt Debt-to-Equity Ratio0.11 Current Ratio2.00 Quick Ratio2.40Price-To-Earnings Trailing P/E Ratio65.79 Forward P/E Ratio56.12 P/E Growth5.61 Sales & Book Value Annual Sales$519.91 million Price / Sales1.31 Cash Flow$0.9958 per share Price / Cash Flow19.16 Book Value$5.10 per share Price / Book3.74Profitability EPS (Most Recent Fiscal Year)$0.29 Net Income$10.84 million Net Margins1.79% Return on Equity4.87% Return on Assets1.68%Miscellaneous Employees482 Outstanding Shares35,770,000Market Cap$682.49 million Next Earnings Date5/21/2019 (Estimated) OptionableNot Optionable Apollo Medical (NASDAQ:AMEH) Frequently Asked Questions What is Apollo Medical's stock symbol? Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH." How were Apollo Medical's earnings last quarter? Apollo Medical Holdings Inc (NASDAQ:AMEH) announced its quarterly earnings results on Monday, March, 18th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.12 by $0.20. The company earned $105.46 million during the quarter. Apollo Medical had a net margin of 1.79% and a return on equity of 4.87%. View Apollo Medical's Earnings History. When is Apollo Medical's next earnings date? Apollo Medical is scheduled to release their next quarterly earnings announcement on Tuesday, May 21st 2019. View Earnings Estimates for Apollo Medical. Has Apollo Medical been receiving favorable news coverage? News articles about AMEH stock have been trending somewhat positive recently, InfoTrie reports. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Apollo Medical earned a daily sentiment score of 1.9 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near term. Who are some of Apollo Medical's key competitors? Some companies that are related to Apollo Medical include RMR Group (RMR), ICF International (ICFI), NIC (EGOV), Huron Consulting Group (HURN), Navigant Consulting (NCI), The Hackett Group (HCKT), Blackrock Capital Investment (BKCC), Avalon Globocare (AVCO), Information Services Group (III), China Internet Nationwide Fncl Srvcs (CIFS), Lightbridge (LTBR), Gopher Protocol (GOPH), Wilhelmina International (WHLM), Pharma Bio Serv (PBSV) and TSS (TSSI). What other stocks do shareholders of Apollo Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include Krystal Biotech (KRYS), Alibaba Group (BABA), Allena Pharmaceuticals (ALNA), Anavex Life Sciences (AVXL), Corbus Pharmaceuticals (CRBP), Gemphire Therapeutics (GEMP), Sorrento Therapeutics (SRNE), Viking Therapeutics (VKTX), Arca Biopharma (ABIO) and Arbutus Biopharma (ABUS). Who are Apollo Medical's key executives? Apollo Medical's management team includes the folowing people: Dr. Kenneth T. Sim M.D., Exec. ChairmanDr. Warren Hosseinion, Co-CEO & Director (Age 47)Dr. Thomas S. Lam, Co-CEO & Director (Age 70)Mr. Eric Chin, Chief Financial OfficerMr. Hing Ang, Chief Operating Officer Who are Apollo Medical's major shareholders? Apollo Medical's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (1.02%), Geode Capital Management LLC (0.53%), Northern Trust Corp (0.33%), Manchester Financial Inc. (0.26%), Swiss National Bank (0.13%) and Dimensional Fund Advisors LP (0.11%). Company insiders that own Apollo Medical stock include Adrian Vazquez and Warren Hosseinion. View Institutional Ownership Trends for Apollo Medical. Which major investors are selling Apollo Medical stock? AMEH stock was sold by a variety of institutional investors in the last quarter, including Royce & Associates LP, Marshall Wace LLP, Wells Fargo & Company MN, Morgan Stanley and New York State Common Retirement Fund. Company insiders that have sold Apollo Medical company stock in the last year include Adrian Vazquez and Warren Hosseinion. View Insider Buying and Selling for Apollo Medical. Which major investors are buying Apollo Medical stock? AMEH stock was purchased by a variety of institutional investors in the last quarter, including Manchester Financial Inc., BlackRock Inc., ExodusPoint Capital Management LP, Strs Ohio, Northern Trust Corp, Geode Capital Management LLC, SG Americas Securities LLC and Dimensional Fund Advisors LP. View Insider Buying and Selling for Apollo Medical. How do I buy shares of Apollo Medical? Shares of AMEH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Apollo Medical's stock price today? One share of AMEH stock can currently be purchased for approximately $19.08. How big of a company is Apollo Medical? Apollo Medical has a market capitalization of $682.49 million and generates $519.91 million in revenue each year. The company earns $10.84 million in net income (profit) each year or $0.29 on an earnings per share basis. Apollo Medical employs 482 workers across the globe. What is Apollo Medical's official website? The official website for Apollo Medical is http://apollomed.net. How can I contact Apollo Medical? Apollo Medical's mailing address is 1668 S. Garfield Avenue 2nd Floor, Alhambra CA, 91801. The company can be reached via phone at 626-282-0288 or via email at [email protected] MarketBeat Community Rating for Apollo Medical (NASDAQ AMEH)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 63 (Vote Outperform)Underperform Votes: 70 (Vote Underperform)Total Votes: 133MarketBeat's community ratings are surveys of what our community members think about Apollo Medical and other stocks. Vote "Outperform" if you believe AMEH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMEH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/19/2019 by MarketBeat.com StaffFeatured Article: What is Liquidity? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.